Bausch + Lomb Corp will pay $1.75 billion to acquire a dry-eye drug from Swiss pharmaceutical giant Novartis, the Wall Street Journal reported on Friday.
(Reporting by Leroy Leo in Bengaluru; Editing by Anil D'Silva)
Bausch + Lomb to buy dry-eye drug from Novartis for $1.75 billion - WSJ
2023-06-30 19:22
Bausch + Lomb Corp will pay $1.75 billion to acquire a dry-eye drug from Swiss pharmaceutical giant Novartis,
You Might Like...
New Book Reveals How Cards and Other Games Impacted the Presidency – From Washington to Biden
Ryan Gosling Tops McAfee’s 2023 Hacker Celebrity Hot List
Brazil traders hold bets on August interest rate cut despite doubts
China powers global aluminium output to record high: Andy Home
Flamingo Las Vegas Opens Gordon Ramsay Burger in Summer 2024
Humana Repeats as U.S. News & World Report’s Best Overall Medicare Advantage Plan Company for Second Year in a Row
Cathay Pacific fires cabin crew over alleged discrimination of passenger on flight from China
Beijing Hyundai cuts asking price for Chongqing auto plant by 30%